High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma
High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma
复制标题
GRK3的高表达与胰腺导管腺癌的良好预后相关
DOI:
10.1016/j.prp.2017.11.013
复制
发表时间:
2018-02-01
影响因子:
2.8
通讯作者:
Zhao, Yu-Pei
中科院分区:
文献类型:
--
作者:
Liu, Wen-Jing;Zhou, Li;Zhao, Yu-Pei
Background: It was found that G-protein-coupled receptor kinase 3 (GRK3) played key biological roles in some cancers. However, its associations with clinicopathologic features and prognosis in pancreatic ductal adenocarcinoma (PDAC) remain unknown.& para;& para; Methods and methods: Expression of GRK3 was detected, using tissue microarray-based immunohistochemistry, in paired formalin-fixed paraffin-embedded tumor and non-tumor samples from 165 patients with PDAC after curative resection, and was further correlated with clinicopathologic parameters and cancer-specific survival (CSS).& para;& para; Results: It was shown that GRK3 expression was much lower in tumor than in non-tumor tissues. Moreover, expression of GRK3 in tumor tissues was significantly associated with gender and T stage. Univariately, high GRK3 expression was predictive for favorable CSS, along with some conventional clinicopathologic variables. In multivariate Cox regression test, GRK3 expression remained to be a significant prognostic marker for PDAC. Finally, combination of GRK3 with some clinicopathologic variables, especially N stage, obtained more precise prediction for CSS.& para;& para; Conclusions: Our data suggested that expression of GRK3 was down-regulated in PDAC and was an independent prognostic factor.